FIELD: medicine, hepatology, pharmaceutical industry.
SUBSTANCE: invention relates to a method for preparing the injection formulation of phospholipid preparation "Fosfogliv" used in treatment and prophylaxis of hepatic diseases. The preparation comprises vegetable phospholipids, glycyrrhizic acid or its salts and carbohydrates and it is prepared by mixing phospholipids, glycyrrhizic acid or its salts and carbohydrates in an aqueous medium followed by homogenization of the prepared emulsion-dispersion mixture under pressure 800-1200 bars, filtration and sublimation drying. The preparation is stable for 3 years.
EFFECT: improved preparing method, valuable medicinal properties of preparation.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NANOFORM OF PHOSPHOLIPID PREPARATION FOR ORAL APPLICATION AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373924C1 |
| PHOSPHOLIPID THERAPEUTIC COMPOSITION WITH NANO-SIZED PARTICLES FOR LIPID STORAGE DISEASE AND COMATOSE STATES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448715C1 |
| METHOD FOR PREPARING CAPSULATED MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304431C2 |
| COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
| PHOSPHOLIPID NANOFORM FOR ORAL APPLICATION (SACHET) AND METHOD FOR PREPARING IT (VERSIONS) | 2010 |
|
RU2463057C2 |
| MEDICAL PRODUCT AND METHOD OF RHEUMATIC DISEASES TREATMENT | 2006 |
|
RU2330664C2 |
| PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
| BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING LIVER DISEASES | 2019 |
|
RU2725622C1 |
| COMPOSITION HAVING THE PROPERTY TO REPAIR HEPATOCYTE MEMBRANES | 1993 |
|
RU2043110C1 |
